Stockscreener 앱 받기
393.21
0.33%
-1.32
시장 영업 전:
392.44
-0.77
-0.20%
Vertex Pharmaceuticals Inc 주식(VRTX)의 최신 뉴스
Fortis Capital Advisors LLC Makes New $850,000 Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Plato Investment Management Ltd Sells 820 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Ilmarinen Mutual Pension Insurance Co Buys 5,000 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
CEO Moves: Is Vertex Pharmaceuticals Incorporated showing insider buyingBreakout Watch & Weekly Top Gainers Trade List - خودرو بانک
1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals - The Globe and Mail
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Cim LLC - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Intech Investment Management LLC - MarketBeat
Advisors Capital Management LLC Trims Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Voleon Capital Management LP Sells 7,475 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Integrity Alliance LLC. Makes New $445,000 Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Boosts Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Fred Alger Management LLC Has $6.46 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Zurich Insurance Group Ltd FI Purchases 158,379 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Peloton Wealth Strategists Raises Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
NewEdge Advisors LLC Has $5.31 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Alaethes Wealth LLC Purchases Shares of 3,051 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
9,601 Shares in Vertex Pharmaceuticals Incorporated $VRTX Purchased by AG2R LA Mondiale Gestion D Actifs - MarketBeat
Voya Investment Management LLC Acquires 128,432 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Swedbank AB Decreases Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Strs Ohio Buys Shares of 77,851 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by McAdam LLC - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Coppell Advisory Solutions LLC - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Woodline Partners LP - MarketBeat
Ascent Group LLC Trims Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Evercore ISI Cuts Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $475.00 - MarketBeat
Vertex Pharmaceuticals: Buying The CF Fortress For The JOURNAVX Optionality (NASDAQ:VRTX) - Seeking Alpha
Focus Partners Wealth Has $69.43 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Belpointe Asset Management LLC Has $1.94 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Gotham Asset Management LLC Cuts Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Curi RMB Capital LLC Has $204,000 Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Sepio Capital LP Purchases 1,311 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
ToolGen and BarentsKrans step up CRISPR battle against Vertex - JUVE Patent
Jacobs Levy Equity Management Inc. Buys Shares of 66,234 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
AQR Capital Management LLC Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis - Business Wire
Evercore ISI Adjusts PT on Vertex Pharmaceuticals to $475 From $510, Maintains Outperform Rating - MarketScreener
Polar Asset Management Partners Inc. Cuts Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
1.02%
2.25%
자본화:
|
볼륨(24시간):